Pharmacotherapy of bulimia nervosa and binge eating disorder: Longer- term outcomes

Psychopharmacology Bulletin

Volumn 33, Issue 3, 1997, Pages 433-436

  Agras, W Stewart ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antidepressant treatment; Binge eating disorder; Bulimia nervosa; Cognitive behavioral therapy; Long term outcome

Indexed keywords

DESIPRAMINE; FLUOXETINE; IMIPRAMINE;

BEHAVIOR THERAPY; BULIMIA; DRUG EFFECT; DRUG EFFICACY; FOLLOW UP; HUMAN; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; BULIMIA; COGNITIVE THERAPY; HUMANS;

EID: 0030982550     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Agras, WS. Treatment of eating disorders. In: Schatzberg, AF, and Nemeroff, CB, eds. Textbook of Psychopharmacology. Washington, DC: American Psychiatric Press, 1995.
2. Agras, WS; Dorian, B; Kirkley, BG; Arnow, B; and Bachman, J. Imipramine in the treatment of bulimia: A double-blind controlled study. Int. J. Eat. Disord. 6:29-38, 1987.
3. Agras, WS; Rossiter, EM; Arnow, B; Schneider, JA; Teich, CF; Raeburn, SD; Bruce, B; Perl, M; and Koran, LM. Pharmacologic and cognitive-behavioral treatment for bulimia nervosa: A controlled comparison. Am. J. Psychiatry 149:82-87, 1992.
4. Agras, WS; Rossiter, EM; Arnow, B; Telch, CF; Raeburn, SD; Bruce, B; and Koran, LM. One-year follow-up of psychosocial and pharmacologic treatments for bulimia nervosa. J. Clin. Psychiatry 55:179-183, 1994a.
5. Agras, WS; Telch, CF; Arnow, B; Eldredge, K; Wilfley, DE; Raeburn, SD; Henderson, J; and Marnell, M. Weight loss, cognitive-behavioral, and desipramine treatments in binge-eating disorder: An additive design. Behav. Ther. 25:225-238, 1994b.
6. Alger, A; Schwalberg, D; and Bigaouette, JM. Effect of a tricyclic antidepressant and opiate antagonist on binge-eating behavior in normoweight bulimic and obese, binge-eating subjects. Am. J. Clin. Nutr. 53:865-871, 1991.
7. Barlow, J; Blouin, J; Blouin, A; and Perez, E. Treatment of bulimia with desipramine: A double-blind crossover study. Can. J. Psychiatry 33:129-133, 1988.
8. Blouin, J; Blouin, A; and Perez, E. Bulimia: Independence of antibulimic and antidepressant properties of desipramine. Can. J. Psychiatry 34:24-29, 1989.
9. Goldstein, DJ; Wilson, MG; Thompson, VL; Potvin, JH; Rampey, AH; and the Fluoxetine Bulimia Nervosa Research Group. Long-term fluoxetine treatment of bulimia nervosa. Br. J. Psychiatry 166:660-666, 1995.
10. Home, RL; Ferguson, JM; Pope, HG; Hudson, JI; Lineberry, CG; Ascher, J; and Cato, A. Treatment of bulimia with bupropion: A multicenter controlled trial. J. Clin. Psychiatry 49:262-266, 1988.
11. Hudson, JI; Pope, HG; Keck, PE; and McElroy, SL. Treatment of bulimia nervosa with trazodone: Short-term response and long-term follow-up. Clin. Neuropharmacol. 12(Suppl. 1):S38-S46, 1989.
12. Hughes, PL; Wells, LA; Cunningham, CJ; and Illstrup, DM. Treating bulimia with desipramine. Arch. Gen. Psychiatry 43:182-186, 1986.
13. Kennedy, SH; Goldbloom, DS; Ralevski, E; Davis, C; D'Souza, JD; and Lofchy, J. Is there a role for selective monoamine oxidase inhibitor therapy in bulimia nervosa? A placebo-controlled trial. J. Clin. Psychopharmacol. 13:415-422, 1993.
14. McCann, UD, and Agras, WS. Successful treatment of nonpurging bulimia nervosa with desipramine: A double-blind, placebo-controlled study. Am. J. Psychiatry 147:876-881, 1990.
15. Mitchell, JE; Pyle, RL; Eckert, ED; Hatsukami, D; Pomeroy, C; and Zimmerman, R. Response to alternative antidepressants in imipramine nonresponders with bulimia nervosa. J. Clin. Psychopharmacol. 9:291-293, 1989.
16. Mitchell, JE; Pyle, RL; Eckert, ED; Hatsukami, D; Pomeroy, C; and Zimmerman, R. A comparison study of antidepressants and structured intensive group psychotherapy in the treatment of bulimia nervosa. Arch. Gen. Psychiatry 47:149-157, 1990.
17. Pope, HG; Hudson, JI; Jonas, JM; and Yurgelun-Todd, D. Bulimia treated with imipramine: A placebo-controlled, double-blind study. Am. J. Psychiatry 140:554-558, 1983.
18. Pope, HG; Hudson, JI; Jonas, JM; and Yurgelun-Todd, D. Antidepressant treatment of bulimia: A two-year follow-up study. J. Clin. Psychopharmacol. 5:320-327, 1985.
19. Pope, HG; Keck, PE; McElroy, SL; and Hudson, JI. A placebo-controlled study of trazodone in bulimia nerovsa. J. Clin. Psychopharmacol. 9:254-259, 1989.
20. Pyle, RL; Mitchell, JE; Eckert, ED; Hatsukami, D; Pomeroy, C; and Zimmerman, R. Maintenance treatment and 6-month outcome for bulimic patients who respond to initial treatment. Am. J. Psychiatry 147:871-875, 1990.
21. Rossiter, EM; Agras, WS; McCann, U; Schneider, JA; and Gotestam, KG. Are antidepressants appetite suppressants in bulimia nervosa? Eur. J. Psychiatry 5:224-231, 1991.
22. Walsh, BT; Gladis, M; Roose, SP; Stewart, SW; Stetner, F; and Glassman, AH. Phenelzine vs. placebo in 50 patients with bulimia. Arch. Gen. Psychiatry 45:471-475, 1988.
23. Walsh, BT; Hadigan, CM; Devlin, MJ; Gladis, M; and Roose, SP. Long-term outcome of antidepressant treatment for bulimia nervosa. Am. J. Psychiatry 148:1206-1212, 1991.
24. Walsh, BT; Stewart, JW; Roose, SP; Gladis, M; and Glassman, AH. Treatment of bulimia with phenelzine. Arch. Gen. Psychiatry 41:1105-1109, 1984.
25. Walsh, BT; Wilson, GT; Loeb, KL; Devlin, MJ; Pike, KM; Roose, SP; Fleiss, J; and Waternaux, C. "Medication and Psychotherapy in the Treatment of Bulimia Nervosa." Presented at the 7th International Conference on Eating Disorders, New York, NY, April 1996.
26. Wermuth, BM; Davis, KL; Hollister, LE; and Stunkard, AJ. Phenytoin treatment of the binge-eating syndrome. Am. J. Psychiatry 134:1249-1253, 1977.